Ribosomal Protein L13 (RPL13) Peptide
RPL13
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all RPL13 products
- RPL13 (Ribosomal Protein L13 (RPL13))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KGDSSAEELK LATQLTGPVM PVRNVYKKEK ARVITEEEKN FKAFASLRMA
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of RPL13 antibody,
Alternative Names: RPL13 control peptide, RPL13 antibody Blocking Peptide, Anti-RPL13 Blocking Peptide, Ribosomal Protein L13 Blocking Peptide, BBC1 Blocking Peptide, D16S444E Blocking Peptide, MGC71373 Blocking Peptide, RPL13, RPL-13, RPL 13, RPL-13 Blocking Peptide, RPL 13 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- RPL13 (Ribosomal Protein L13 (RPL13))
- Background
- Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. RPL13 is a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L13E family of ribosomal proteins. It is located in the cytoplasm. This gene is expressed at significantly higher levels in benign breast lesions than in breast carcinomas.
- Molecular Weight
- 23 kDa
-
You are here:
